Drug Type CAR-T |
Synonyms ACLX-003 |
Target- |
Mechanism Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | - | 27 Apr 2022 | |
Myelodysplastic Syndromes | Preclinical | - | 27 Apr 2022 |